跳至主要内容
临床试验/NCT06560892
NCT06560892已完成不适用

Comparison Between Mean Duration of Post-operative Analgesia of Intraperitoneal Bupivacaine Alone or With Dexmedetomidine Following Laparoscopic Cholecystectomy

RESnTEC, Institute of Research1 个研究点 分布在 1 个国家目标入组 68 人开始时间: 2024年1月1日最近更新:
适应症
干预措施

试验速览

阶段
不适用
状态
已完成
入组人数
68
试验地点
1
主要终点
Duration of analgesia

研究概览

简要总结

For patients with symptomatic cholelithiasis, laparoscopic cholecystectomy (LC) is a customary procedure for treatment these days. After LC, patients may experience considerable pain. This study was performed with the objective of comparing the mean duration of analgesia of intraperitoneal bupivacaine with dexmedetomidine to intraperitoneal bupivacaine alone in patients undergoing laparoscopic cholecystectomy.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Other
盲法
None

入排标准

年龄范围
20 Years 至 70 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Patients of either gender
  • Aged between 20 and 70 years
  • ASA (American Society of Anesthesiologists Classification) physical status I and II
  • Undergoing Laparoscopic Cholecystectomy under general anesthesia

排除标准

  • Patients sensitive to local anesthetics
  • Patients with acute cholecystitis, choledocholithiasis, or ascending cholangitis (temperature≥38.6°C, serum bilirubin≥1.2mg/dl, and ultrasound showing common bile duct diameter of ≥1cm).
  • Patients with uncontrolled diabetes (FBS≥110 mg/dl)
  • Uncontrolled blood pressure (SBP≥140 mmHg)
  • Ischemic heart disease (EF≤40%)
  • Pulmonary dysfunction (FEV≤70 percent of normal)

研究组 & 干预措施

Bupivacaine group

Experimental

Patients received intraperitoneal bupivacaine 50 ml 0.25% + 5 ml normal saline

干预措施: Bupivacaine injection (Drug)

Bupivacaine + Dexmedetomidine group

Experimental

Patients were given intraperitoneal bupivacaine 50 ml 0.25% + dexmedetomidine 1 μg/kg with normal saline 5 ml

干预措施: Bupivacaine injection (Drug)

Bupivacaine + Dexmedetomidine group

Experimental

Patients were given intraperitoneal bupivacaine 50 ml 0.25% + dexmedetomidine 1 μg/kg with normal saline 5 ml

干预措施: Dexmedetomidine injection (Drug)

结局指标

主要结局

Duration of analgesia

时间窗: 24 hours

The duration of postoperative analgesia was calculated as the time in minutes starting after the dressing of the patient in the operation room until the patient had a VAS≥3.

次要结局

未报告次要终点

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Muhammad Aamir Latif

Research Consultant

RESnTEC, Institute of Research

研究点 (1)

Loading locations...

相似试验